Incannex September 2021 Quarterly Activities Report and Appendix 4C Oct 29, 2021 | ASX News, Incannex Healthcare (ASX:IHL)
Incannex expands IHL-675A indications to include COPD, asthma, bronchitis, and other inflammatory lung conditions – after receiving positive results from additional in vivo studies Feb 4, 2021 | ASX News, Incannex Healthcare (ASX:IHL)
S & P Dow Jones Indices Announce March 2021 Rebalance of the Indices Mar 12, 2021 | ASX News, Pointerra (ASX:3DP)